MARAVAI LIFESCIENCES HOLDINGS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.83 USD | +1.69% |
|
+6.31% | +19.62% |
| 04-18 | Maravai LifeSciences Unit Opens New Manufacturing Facility in San Diego | MT |
| 04-10 | Craig-Hallum Initiates Coverage on Maravai LifeSciences With Buy Rating, $15 Price Target | MT |
Chart calendar Maravai LifeSciences Holdings, Inc.
9ae858355a76bf776e7d2122125c8._CrtvstkW4T4Y6bkpj8jTMIVaCnBYDOvJo-y03o-Z2k.xX2u7bFTAvSNN8KmwFZEFJhcLEGbP0rwaMLH4xdNDVyZWYjvilcE1r4A5w~9ec5735994370bb8e73a6648f8c9cd32
Upcoming events on Maravai LifeSciences Holdings, Inc.
Past events on Maravai LifeSciences Holdings, Inc.
| 19/03/2024 18:15 | KeyBanc Life Sciences & MedTech Forum |
| 22/02/2024 22:00 | Q4 2023 Earnings Call |
| 22/02/2024 21:05 | Q4 2023 Earnings Release |
| 16/11/2023 14:00 | Jefferies London Healthcare Conference |
| 07/11/2023 22:00 | Q3 2023 Earnings Call |
| 07/11/2023 21:05 | Q3 2023 Earnings Release |
| 28/09/2023 15:00 | R&D Day |
| 16/08/2023 22:00 | UBS MedTech Tools and Genomics Summit |
| 07/08/2023 22:00 | Q2 2023 Earnings Call |
| 07/08/2023 21:05 | Q2 2023 Earnings Release |
| 18/05/2023 22:30 | Annual General Meeting |
| 08/05/2023 22:00 | Q1 2023 Earnings Call |
| 08/05/2023 21:05 | Q1 2023 Earnings Release |
| 27/03/2023 | SVB Securities Foundations of Discovery Drugs and Dx Conference |
| 21/03/2023 16:45 | KeyBanc Life Sciences & MedTech Forum |
| 15/03/2023 21:00 | Barclays Global Healthcare Conference |
| 22/02/2023 22:00 | FY 2022 Earnings Call |
| 22/02/2023 21:05 | FY 2022 Earnings Release |
| 06/12/2022 10:00 | Nasdaq Investor Conference |
| 08/11/2022 20:50 | Credit Suisse Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 284 275 3.21% | 799 779 2.58% | 883 883 -0.05% | 289 279 3.47% | 272 |
|
EBITDA Million USD | Released Forecast Spread | 169 147 14.95% | 583 571 2.1% | 638 651 -2.09% | 65,3 56,2 16.17% | 62,1 |
|
EBIT Million USD | Released Forecast Spread | 143 133 7.95% | 558 539 3.59% | 606 620 -2.2% | 25,1 18,8 33.58% | 20,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 81,7 99,1 -17.53% | 531 520 2.02% | 551 586 -5.93% | 618 -57,3 1177.74% | -32,7 |
|
Net income Million USD | Released Forecast Spread | 89,0 76,9 15.67% | 182 299 -39.14% | 220 269 -18.12% | -119 -26,4 -350.42% | -13,5 |
|
EPS USD | Released Forecast Spread | 0,35 0,31 12.53% | 1,56 1,24 25.77% | 1,67 1,27 31.95% | -0,90 -0,09 -872.97% | -0,10 |
| Announcement Date | 02/03/21 | 23/02/22 | 22/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 228 208 9.78% | 244 232 5.17% | 243 233 4.08% | 191 196 -2.23% | 205 205 -0.12% | 79,0 79,7 -0.88% | 68,9 71,1 -3.11% | 66,9 75,5 -11.46% | 74,1 64,3 15.23% | 60,5 | 66,8 | 69,7 | 74,4 | 68,6 |
|
EBITDA Million USD | Released Forecast Spread | 163 151 7.91% | 187 162 15.51% | 188 166 13.36% | 133 129 2.46% | 130 143 -9.48% | 23,8 26,2 -9.05% | 9,08 17,3 -47.56% | 11,9 15,4 -22.62% | 20,5 11,4 80.62% | 8,93 | 14,9 | 16,7 | 20,8 | 15,3 |
|
EBIT Million USD | Released Forecast Spread | 157 142 10.65% | 180 156 15.4% | 180 158 14.29% | 124 119 4.94% | 122 135 -9.88% | 15,0 17,3 -13.48% | -0,59 7,02 -108.4% | 0,96 7,34 -86.93% | 9,73 1,33 630.28% | -2,10 | 3,78 | 6,83 | 11,4 | 8,10 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 145 130 11.09% | 167 149 12.1% | 175 152 15.48% | 114 106 7.63% | 95,9 122 -21.54% | -4,52 10,3 -144.11% | -13,4 0,90 -1580.55% | -20,6 -2,70 -660.96% | 656 -13,9 4820.76% | -14,9 | -9,39 | -7,39 | -3,40 | 1,24 |
|
Net income Million USD | Released Forecast Spread | 55,8 76,8 -27.31% | 66,9 88,3 -24.3% | 71,2 90,1 -20.97% | 44,5 52,2 -14.81% | 37,6 61,2 -38.5% | -0,07 4,15 -101.61% | -6,54 0,51 -1371.92% | -6,46 -2,08 -211.28% | -106 -6,18 -1615.94% | -8,01 | -5,25 | -3,67 | -1,08 | -0,92 |
|
EPS USD | Released Forecast Spread | 0,42 0,39 8.09% | 0,50 0,39 26.88% | 0,53 0,38 40.37% | 0,34 0,29 16.26% | 0,28 0,27 3.5% | 0,00 0,02 - | -0,05 0,00 -2037.98% | -0,05 -0,01 -496.66% | -0,80 -0,02 -3329.06% | -0,05 | -0,03 | -0,03 | 0,00 | 0,02 |
| Announcement Date | 23/02/22 | 05/05/22 | 04/08/22 | 02/11/22 | 22/02/23 | 08/05/23 | 07/08/23 | 07/11/23 | 22/02/24 | - | - | - | - | - |
| 01/05/2024 | CAREDX, INC: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | IOVANCE BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 21:05 | VERACYTE, INC.: Q1 2024 Earnings Release |
| 08/05/2024 21:05 | MARAVAI LIFESCIENCES HOLDINGS, INC.: Q1 2024 Earnings Release |
| 08/05/2024 21:05 | EXACT SCIENCES CORPORATION: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | GUARDANT HEALTH, INC.: Q1 2024 Earnings Release |
| 12/05/2024 | SEEGENE, INC.: Q1 2024 Earnings Release (Projected) |
| 29/07/2024 | VERACYTE, INC.: Q2 2024 Earnings Release (Projected) |
| 29/07/2024 | EXACT SCIENCES CORPORATION: Q2 2024 Earnings Release (Projected) |
| 30/07/2024 | ADAPTIVE BIOTECHNOLOGIES CORPORATION: Q2 2024 Earnings Release (Projected) |
Past sector events for Maravai LifeSciences Holdings, Inc.
| 26/04/2024 | BGI GENOMICS CO., LTD.: Q1 2024 Earnings Release |
| 12/04/2024 | BGI GENOMICS CO., LTD.: Q4 2023 Earnings Release |
| 28/02/2024 21:05 | CAREDX, INC: Q4 2023 Earnings Release |
| 28/02/2024 21:01 | IOVANCE BIOTHERAPEUTICS, INC.: Q4 2023 Earnings Release |
| 22/02/2024 21:05 | VERACYTE, INC.: Q4 2023 Earnings Release |
| 22/02/2024 21:05 | GUARDANT HEALTH, INC.: Q4 2023 Earnings Release |
| 22/02/2024 21:05 | MARAVAI LIFESCIENCES HOLDINGS, INC.: Q4 2023 Earnings Release |
| 21/02/2024 21:05 | EXACT SCIENCES CORPORATION: Q4 2023 Earnings Release |
| 15/02/2024 | SEEGENE, INC.: Q4 2023 Earnings Release |
| 09/11/2023 | SEEGENE, INC.: Q3 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MRVI Stock
- Calendar Maravai LifeSciences Holdings, Inc.
